FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385691237> ?p ?o ?g. }

• W4385691237 endingPage "e0001328" @default.
• W4385691237 startingPage "e0001328" @default.
• W4385691237 abstract "Ghana introduced rotavirus vaccine (ROTARIX 1-dose presentation) into the routine national immunization program in 2012 and switched to a different product (ROTAVAC 5-dose presentation) in 2020. ROTAVAC has a lower price per dose (US$0.85 versus US$2.15 for ROTARIX) and smaller cold chain footprint but requires more doses per regimen (three versus two). This study estimates the supply chain and service delivery costs associated with each product, the costs involved in switching products, and compares the cost-effectiveness of both products over the next ten years. We estimated the supply chain and service delivery costs associated with ROTARIX and ROTAVAC (evaluating both the 5-dose and 10-dose presentations) using primary data collected from health facilities in six of the 14 regions in the country. We estimated the costs of switching from ROTARIX to ROTAVAC using information collected from key informant interviews and financial records provided by the government. All costs were reported in 2020 US$. We used the UNIVAC decision-support model to evaluate the cost-effectiveness (US$ per disability-adjusted life-year (DALY) averted from government and societal perspectives) of ROTARIX and ROTAVAC (5-dose or 10-dose presentations) compared to no vaccination, and to each other, over a ten-year period (2020 to 2029). We ran probabilistic sensitivity analyses and other threshold analyses. The supply chain and service delivery economic cost per dose was $2.40 for ROTARIX, $1.81 for ROTAVAC 5-dose, and $1.76 for ROTAVAC 10-dose. The financial and economic cost of switching from ROTARIX to ROTAVAC 5-dose was $453,070 and $883,626, respectively. Compared to no vaccination, the cost per DALY averted was $360 for ROTARIX, $298 for ROTAVAC 5-dose, and $273 for ROTAVAC 10-dose. ROTAVAC 10-dose was the most cost-effective option and would be cost-effective at willingness-to-pay thresholds exceeding 0.12 times the national GDP per capita ($2,206 in the year 2020). The switch from ROTARIX to ROTAVAC 5-dose in 2020 was cost-saving. Rotavirus vaccination is highly cost-effective in Ghana. A switch from ROTAVAC 5-dose to ROTAVAC 10-dose would be cost-saving and should be considered." @default.
• W4385691237 created "2023-08-10" @default.
• W4385691237 creator A5001664813 @default.
• W4385691237 creator A5004383063 @default.
• W4385691237 creator A5012999839 @default.
• W4385691237 creator A5033151792 @default.
• W4385691237 creator A5052096911 @default.
• W4385691237 creator A5073644479 @default.
• W4385691237 creator A5077525484 @default.
• W4385691237 creator A5081321539 @default.
• W4385691237 creator A5084128747 @default.
• W4385691237 creator A5086780182 @default.
• W4385691237 creator A5089513385 @default.
• W4385691237 creator A5091770714 @default.
• W4385691237 date "2023-08-09" @default.
• W4385691237 modified "2023-09-27" @default.
• W4385691237 title "Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness" @default.
• W4385691237 cites W197831564 @default.
• W4385691237 cites W2014855816 @default.
• W4385691237 cites W2023400892 @default.
• W4385691237 cites W2031363511 @default.
• W4385691237 cites W2058909545 @default.
• W4385691237 cites W2090417453 @default.
• W4385691237 cites W2101380815 @default.
• W4385691237 cites W2136662296 @default.
• W4385691237 cites W2158543557 @default.
• W4385691237 cites W2489544906 @default.
• W4385691237 cites W2626345486 @default.
• W4385691237 cites W2733199975 @default.
• W4385691237 cites W2765323591 @default.
• W4385691237 cites W2771822488 @default.
• W4385691237 cites W2793514345 @default.
• W4385691237 cites W2894020737 @default.
• W4385691237 cites W2898307104 @default.
• W4385691237 cites W2906376846 @default.
• W4385691237 cites W2910463736 @default.
• W4385691237 cites W2912128032 @default.
• W4385691237 cites W2921469132 @default.
• W4385691237 cites W2948888508 @default.
• W4385691237 cites W2960362993 @default.
• W4385691237 cites W2980070413 @default.
• W4385691237 cites W2987270357 @default.
• W4385691237 cites W2995830815 @default.
• W4385691237 cites W3005136163 @default.
• W4385691237 cites W3023953619 @default.
• W4385691237 cites W3033798982 @default.
• W4385691237 cites W3033849171 @default.
• W4385691237 cites W3092849554 @default.
• W4385691237 cites W3181487322 @default.
• W4385691237 cites W3183521817 @default.
• W4385691237 cites W3205687121 @default.
• W4385691237 cites W3214458626 @default.
• W4385691237 cites W3214603815 @default.
• W4385691237 cites W4200392395 @default.
• W4385691237 cites W4214923194 @default.
• W4385691237 doi "https://doi.org/10.1371/journal.pgph.0001328" @default.
• W4385691237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37556413" @default.
• W4385691237 hasPublicationYear "2023" @default.
• W4385691237 type Work @default.
• W4385691237 citedByCount "0" @default.
• W4385691237 crossrefType "journal-article" @default.
• W4385691237 hasAuthorship W4385691237A5001664813 @default.
• W4385691237 hasAuthorship W4385691237A5004383063 @default.
• W4385691237 hasAuthorship W4385691237A5012999839 @default.
• W4385691237 hasAuthorship W4385691237A5033151792 @default.
• W4385691237 hasAuthorship W4385691237A5052096911 @default.
• W4385691237 hasAuthorship W4385691237A5073644479 @default.
• W4385691237 hasAuthorship W4385691237A5077525484 @default.
• W4385691237 hasAuthorship W4385691237A5081321539 @default.
• W4385691237 hasAuthorship W4385691237A5084128747 @default.
• W4385691237 hasAuthorship W4385691237A5086780182 @default.
• W4385691237 hasAuthorship W4385691237A5089513385 @default.
• W4385691237 hasAuthorship W4385691237A5091770714 @default.
• W4385691237 hasBestOaLocation W43856912371 @default.
• W4385691237 hasConcept C112930515 @default.
• W4385691237 hasConcept C144133560 @default.
• W4385691237 hasConcept C162324750 @default.
• W4385691237 hasConcept C21547014 @default.
• W4385691237 hasConcept C3019080777 @default.
• W4385691237 hasConcept C515549039 @default.
• W4385691237 hasConceptScore W4385691237C112930515 @default.
• W4385691237 hasConceptScore W4385691237C144133560 @default.
• W4385691237 hasConceptScore W4385691237C162324750 @default.
• W4385691237 hasConceptScore W4385691237C21547014 @default.
• W4385691237 hasConceptScore W4385691237C3019080777 @default.
• W4385691237 hasConceptScore W4385691237C515549039 @default.
• W4385691237 hasFunder F4320306137 @default.
• W4385691237 hasIssue "8" @default.
• W4385691237 hasLocation W43856912371 @default.
• W4385691237 hasLocation W43856912372 @default.
• W4385691237 hasOpenAccess W4385691237 @default.
• W4385691237 hasPrimaryLocation W43856912371 @default.
• W4385691237 hasRelatedWork W2001644930 @default.
• W4385691237 hasRelatedWork W2015761230 @default.
• W4385691237 hasRelatedWork W2040293510 @default.
• W4385691237 hasRelatedWork W2057711323 @default.
• W4385691237 hasRelatedWork W2076833676 @default.
• W4385691237 hasRelatedWork W2266642512 @default.

• next